George L. Sing - 03 May 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**George L. Sing
Issuer symbol
REGN
Transactions as of
03 May 2024
Net transactions value
+$61.19
Form type
4
Filing time
06 May 2024, 16:20:02 UTC
Previous filing
28 Feb 2024
Next filing
05 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $826,660 +2,000 +7.6% $413.33 28,349 03 May 2024 Direct
transaction REGN Common Stock Tax liability $826,599 -877 -3.1% $942.53 27,472 03 May 2024 Direct
holding REGN Common Stock 750 03 May 2024 by Spouse
holding REGN Common Stock 400 03 May 2024 by Spouse/Cust Son
holding REGN Common Stock 1,000 03 May 2024 by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,000 -37% $0.000000 3,338 03 May 2024 Common Stock 2,000 $413.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.